Furthermore, through the NRG1-HER3 signaling axis, NRG1 contributes to malignant tumor development in certain cancer types, including gastric, pancreatic, and breast cancer, and its overexpression is closely associated with poor prognosis7,8. Here, NRG1 is linked to breast cancer.